Glaucoma Therapeutics Market Scope And Analysis

  • Report Code : TIPRE00018828
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 150
Buy Now

Glaucoma Therapeutics Market Report Scope 2021 to 2031

Buy Now

Glaucoma Therapeutics Market Report Glaucoma Therapeutics Market Size and Share Glaucoma Therapeutics Market Scope and Analysis

Glaucoma Therapeutics Market Report Scope

Report Attribute Details
Market size in 2022 US$ 6.24 Billion
Market Size by 2031 US$ 8.02 Billion
Global CAGR (2021 - 2031) 3.2%
Historical Data 2021-2022
Forecast period 2023-2031
Segments Covered By Drug Class
  • Beta Blockers
  • Alpha Adrenergic Agonists
  • Prostaglandins Analogues
  • Carbonic Anhydrase Inhibitors
  • Combination Drugs
By Drug Class
  • Beta Blockers
  • Alpha Adrenergic Agonists
  • Prostaglandins Analogues
  • Carbonic Anhydrase Inhibitors
  • Combination Drugs
By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Alcon AG
  • AbbVie Inc
  • Bausch Lomb Inc
  • Fera Pharmaceuticals LLC
  • Viatris Inc
  • Novartis AG
  • Sun Pharmaceutical Industries Ltd
  • Teva Pharmaceutical Industries Ltd
  • Thea Pharma Inc
  • Santen Pharmaceutical Co Ltd